Achieve Life Sciences (ACHV) Operating Income (2010 - 2012)
Achieve Life Sciences (ACHV) posted Operating Income of $8.3 million for Q3 2012, up 39.47% on a QoQ basis from $5.9 million in Q2 2012, and up 102.34% year-over-year from $4.1 million in Q4 2011.
Achieve Life Sciences (ACHV) Operating Income (2010 - 2012) Analysis & Trends
Achieve Life Sciences' Operating Income history runs 3 years deep, the most recent figure standing at $8.3 million for Q3 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -15.76 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 249.90 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 394.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -445.22 Mn |
| 10 | Achieve Life Sciences | 326.16 Mn | 326.16 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2012 | 8.29 Mn |
| Jun 30, 2012 | 5.94 Mn |
| Mar 31, 2012 | -5.50 Mn |
| Sep 30, 2011 | 4.10 Mn |
| Jun 30, 2011 | 4.99 Mn |
| Mar 31, 2011 | -5.23 Mn |
| Sep 30, 2010 | -6.95 Mn |
| Jun 30, 2010 | -2.85 Mn |